Christopher Cano
2020
In 2020, Christopher Cano earned a total compensation of $1.4M as COO and VP of Business Development at TFF Pharmaceuticals.
Compensation breakdown
| Bonus | $65,000 |
|---|---|
| Option Awards | $1,054,733 |
| Salary | $278,125 |
| Total | $1,397,858 |
Cano received $1.1M in option awards, accounting for 75% of the total pay in 2020.
Cano also received $65K in bonus and $278.1K in salary.
Rankings
In 2020, Christopher Cano's compensation ranked 7,160th out of 13,090 executives tracked by ExecPay. In other words, Cano earned more than 45.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,160 out of 13,090 | 45th |
Division Manufacturing | 2,992 out of 5,624 | 47th |
Major group Chemicals And Allied Products | 1,207 out of 2,257 | 47th |
Industry group Drugs | 1,040 out of 1,957 | 47th |
Industry Pharmaceutical Preparations | 775 out of 1,462 | 47th |
Source: SEC filing on September 21, 2022.
Cano's colleagues
We found two more compensation records of executives who worked with Christopher Cano at TFF Pharmaceuticals in 2020.